chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4/30/21 Patient presents to the ED w/complaint of SOB x 2 days. He had rales on exam and RA pulse ox was 88-90%. Troponin was elevated and EKG showed lateral ST-T wave changes. Pt was admitted for COVID and NSTEMI. NSTEMI Hx of CAD sp CABG Presented with dyspnea, Trop of 382, trended up to 859, now trending down CXR with findings of pulmonary edema Started on lovenox, aspirin, coreg, statin Cardiology consulted TTE showed  EF 50 %, normal diastolic dysfunction, moderate AV stenosis S/P Cardiac cath 5/3 with severe disease of SVG to Diag with successful PCI Continue aspirin, plavix, statin, coreg Follow up with cardiac rehab once he has completed quarantine 10 days after 4/29   Pulmonary Edema Acute HFpEF CXR with findings of mild/early bilateral pulmonary edema.  NT ProBNP of 3081 Started on IV lasix and improved Lasix stopped 5/3 due to improvement in symptoms and worsening Na TTE as above Monitor intake and output   COVID 19 infection Symptoms of exertional SOB of 2 days Diagnosed on 4/29 Has received two doses of Pfizer Vaccine, last dose 1 month ago per patient CXR Low lung volume examination with findings suggestive of mild/early bilateral pulmonary edema.  Was on 2L oxygen, now on RA after diuresis Doubt symptoms are due to COVID-19 and suspect more likely cardiac in origin given rapid improvement of oxygen status with dose of lasix Inflammatory markers also not elevated held off on decadron and remdesivir due to patient not requiring oxygen Complete 10 days of quarantine  Patient was discharged home on 5/5/21
Information has been received from a LPN concerning a female who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 646159/0287N). The pt was reported to have received the vaccine in the past 10 years and is 60 years old or older. Subsequently the pt experienced an injection site reaction with redness and warmth spreading to the entire upper arm. The pt was treated with Cefzil for 3 days and Bextra for 6 days. The medications were started on 11/20/03, and the symptoms have not yet resolved. No further information was available at the time of the report. Unspecified medical attention was sought. There was no product quality complaint; however it was noted that the physician questioned the "stability of the vaccine". The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. The reporter also indicated that 2 male pt's were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 646159/0287N) and experienced a similar event (WAES # 0311USA02683).  Additional information has been requested.
Mom called to report 2 days after child received vaccines that she noted child's left upper arm to be very swollen and warm to touch "from just above his elbow all the way up".  Child afebrile et denies any other problesm.  Denies any problems with previous vaccines.  Advised to consult child's Dr.  Subsequently, Dr. office called to report that child had cellulitis and INSISTED that VAERS be completed.  A report was completed on 6/20/03, but CDC states they do not have the report.
no vaccination adverse event, but patient presented to the ED on 9/11/2023 with shortness of breath and non-productive cough.  Tested positive for COVID.  Admitted to the Adult Care Unit the same day due to concern for multifocal lung infiltrates in the setting of pulmonary fibrosis.  Received antibiotics (ceftriaxone/azithromycin) and a course of remdesivir/steroids during admission.
He Missed the Second which was scheduled for March2021; tested positive for COVID-19; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) and PRODUCT DOSE OMISSION ISSUE (He Missed the Second which was scheduled for March2021) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (He Missed the Second which was scheduled for March2021). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (He Missed the Second which was scheduled for March2021) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information included, COVID-19 Antibody Infusion was provided.
CHILLS; FEVER; TIREDNESS; BODY ACHES, ACHES AND PAINS; This spontaneous report received from a patient concerned a 42 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included antibiotics allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced body aches, aches and pains. On 26-MAR-2021, the subject experienced fever. On 26-MAR-2021, the subject experienced tiredness. Laboratory data included: Body temperature (NR: not provided) 99.3 deg. On 04-APR-2021, the subject experienced chills. Laboratory data included: Body temperature (NR: not provided) 99.3 deg. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tiredness on 28-MAR-2021, and had not recovered from fever, body aches, aches and pains, and chills. This report was non-serious.
Vaccine given 10-24 305pm, Monday. Tuesday swelling at site, Wed. swelling to half dollar, red, Thursday feeling better.
Extreme fatique (12 hours (post vaccine) -24 hours) Fatique (24 - 108 hours Severe Headache (12 hours - 60 hours) Nausea (60 hours - 110 hours) Stomach pain (60 hours - 110 hours) Constipation (60 hours - 114 hours and counting)
I was very congested, no fever, I was not achy, no vomiting, I did not test positive with a home test. I went to the doctor to get something for my congestion, it was mostly bronchial congestion. At the doctor's office they tested me for COVID-19, Influenza, RSV, the COVID -19 test did come back positive. I was not prescribed the antiviral. I was on an antibiotic as I had just come home from the hospital and was on antibiotics. It did take me two weeks to recover from having CVOID-19.
I was having chest pains and headaches, so I took my blood pressure at home. It was high enough that I needed to go into the local urgent care. I was given intravenous hydralazine to help get my blood pressure down. I will be having a follow up visit with my PCP today to hopefully learn more.
Tongue soreness initially and especially along the edges around 6:30 pm on 4/27/21, 4 hours after vaccination. Consistent non stop pain of tongue that only lessened around 6am on 4/29/21. Felt like it had been burned but had not eaten anything hot to cause. Glossitis. Realized evening of 4/28/21 sores were on the tip and bottom of the tongue.  At 5am on 4/29/21 sores were more pronounced and pain was not getting better so went to urgent care that morning.  Valtrex 1 gram tablet, 2 by mouth to be taken in am and pm, qty 4 were prescribed as well as magic mouthwash, 5 ml 4 times daily as needed. Took medications as prescribed. 4/29/21  6am, tongue finally only irritated and not full pain without using the mouth wash so seems to be getting better after treatment.
About 40 to 50 shingles or chicken pox like bumps on left and right torso and legs
I went to the Pharmacy and had my 3rd Vaccine. I waited my 15 minutes and went home. I was a bit sore that day and then 3 days later I woke up with my eyes very itchy and swollen. I went to the Doctor for this. They send me various medication. Then the itchiness starting all over my body. My neck, and behind my ears were the worst spots. I still have the itchiness not as bad but it continues.
Pt started complaining of blacking out about 10 minutes into her observation period after she took the COVID vaccine shot. She complained of Blacking out and she requested to use the bathroom. When she returned from the rest room, I had her lie flat on her back with her feet elevated. I observed her for 3 minutes ,and she was breathing normally and remained conscious and she said she was feeling better. I took her blood pressure and pulse at intervals of 5 minutes. Her readings were 95/68,pulse 68;91/67,pulse 64;99/68,pulse,66;99/73,pulse 57. Her mom came about 30 minutes later. I advised mom to keep an eye on her and to give Pedialyte and continue to monitor her BP and pulse. I suggested Benadyl  25mg  pill to her. I advised her that if her situation deteriorates she should take her to  the ER. I also advised her to contact her primary care  doctor. The mother then took her home
Vomited a few times in daycare and  was unresponsive for a few minutes.  Rescue was called. He was checked. Vitals were ok. Blood glucose was normal. Seen in clinic later at around 4 PM and he was alert with normal vital signs. No rash.
Mild dizziness immediately after vaccination was administered. Lasted approx 5 minutes and self resolved. Normal neuro examination per provider.
One day prior to the clinic on 5/18/22, an email was sent to the pharmacy with a list of patients that needed boosters. At the start of the clinic on 5/19/22, copies of vaccine cards for these patients were given to the pharmacy staff. All cards were checked by the pharmacy to ensure eligibility for boosters. Vaccine administration started at 1pm. At approximately 1:20pm, after 14 vaccines were given, a person alerted the pharmacy that the copies of vaccine cards and emailed list were not up-to-date. After consulting with the person, who had an updated list of vaccine records, it was determined that six patients were given a booster shot when not eligible. Consulted with the pharmacy team on how to follow-up and proceed with the clinic. Going forward, each patient vaccinated had their records verified on the system and online. Emailed list was cross-checked with the updated list. Even with updated list from facility, errors were found with vaccine records not being up-to-date and inconsistencies. Photos of covid vaccination cards were taken for records and vaccination cards were sorted.  Patient recieved second booster but did not qualify for second booster.
Date of Admission: 11/28/2022   Date of Discharge: 12/4/2022   Admission Diagnosis: Pregnant state, incidental [Z33.1] Labor and delivery indication for care or intervention [O75.9] Intractable headache   Hospital Principal Problem (Discharge Diagnoses): Idiopathic intracranial hypertension Spinal Headache following LP
left knee effusion without trauma or prior history of knee issue.  warmth, some pain.  ? reactive arthritis.  started 1 day following vaccine.
Patient received the Covid-19 vaccine. She reports symptoms of dizziness, full feeling in the head, sweaty palms.  Patient has history of POTS, states she experiences same symptoms when ill {Immediate reaction less than 1 hour:5552530}. I have observed sweaty palms, hypertension.  No shortness of breath or rash noted.  Vital signs were taken as follows: 1055:  BP 154/82, HR 90, O2 sat 97%. 1100:  BP 148/104, HR 96, O2 sat 100%. 1106:  BP 142/85, HR 72, O2 sat 100% 1111:  BP 147/83, HR 63, O2 sat 100%  1117:  BP 145/93, HR 59, sat 100% 1125:  BP 146/86, HR 65, O2 sat 100%  Patient waited for 35 minutes; reported improvement of symptoms.  HR decreased, was able to ambulate without dizziness, and was discharged home at 1130.  No shortness of breath or rash noted.***
pt presented to clinic 3 days p/vax to show local rxn to Td on rt arm;red swollen area measures 5 1/2inches;denies pain;no fever, no n/v;
Day 1, 10/26/11, Patient symptoms: warm, red, swollen area (approximately 6" oval) around injection site on left arm. Left arm felt stiff, painful. Patient had sensation of tendonitis in deltoid musculature (popping, catching, sensation) when actively using left arm. Patient felt fatigued around 1600. Symptoms waxed and waned. Treatment: Patient took 400 mg of ADVIL at 11:30 and at 18:30. Day 2, 10/27, Patient symptoms: generalized fatigue; mild runny nose, chills. Left upper arm pain radiated into the left side of neck, chest wall, axilla, scapula region and extended through the full length of the left arm. Patient's tendonitis sensations increased, involving shoulder flexor and extensor muscles, elbow flexor, extensor and supinator muscles and wrist flexors. Left arm joint pain increased, especially in the elbow. Deltoid region felt warm to the touch. Symptoms waxed and waned. Day 3-4, 10/28-29, Patient symptoms: generalized fatigue, mild runny nose, heaviness in chest, rash on chest, left arm and face, chills. Left arm tendonitis sensations as described in day 2 increased, and on day 4, included mild numbness on the left side of face, left axilla and throughout length of left arm. The numb sensations lasted for a few hours. Symptoms waxed and waned. Day 5, 10/30, Patient symptoms: generalized fatigue, mild runny, stuffy nose and sinuses; left arm tendonitis decreased; warmth in deltoid region, chills. Symptoms waxed and waned. Day 6, 10/31, patient symptoms: sneezing, mild runny nose, sinus pain, hoarse voice, chills. Symptoms waxed and waned. Symptoms stopped by day 7, Nov 1.
PEELING FINGERS AND TOES BEGAN ON 12-30-21 TX: AQUAPHOR OR VASELINE WILL REFER TO DERMATOLOGIST IF PEELING WORSENS
Vaccine indicated for 18 years of age and older patient 2 months short of age requirement
PATIENT'S REPRESENTATIVE ENTERED DATE OF BIRTH INCORRECTLY WHEN FILLING OUT THE FORM MAKING THE PATIENT 13 YEARS OLD WHEN IN ACTUALITY THE PATIENT WAS 11 YEARS OLD AND SHOULD HAVE RECEIVED THE PEDIATRIC PFIZER VACCINE. DOSE WAS ALREADY GIVEN WHEN THE ERROR WAS DISCOVERED. PHARMACIST INFORMED THE PATIENT AND HER GUARDIAN (MOTHER) THAT DUE TO THE AGE DISCREPANCY THE CHILD WAS GIVEN AN ADULT DOSE AND NOT THE PEDIATRIC DOSE THAT WOULD HAVE BEEN INDICATED.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022; No adverse event; Administered the vaccine after 30 day by use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after 30 day by use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after 30 day by use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after 30 day by use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after 30 day by use by date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022).    No concomitant medications were reported.   The patient received half dose. The vial did not undergo any temperature excursions.  No treatment details were reported.
Information has been received from a nurse concerning her 15 year old daughter who on 17-MAR-2007 was vaccinated with a dose of Gardasil, IM. Concomitant medication was not reported. On 17-MAR-2007, the patient experienced pain at the injection site immediately after vaccination with Gardasil. The pain resolved by the end of the day. On 20-MAR-2007 (three days later), the pain came back and it was associated with nausea and fever. The patient sought unspecified medical attention. It was also mentioned that no other vaccinations were administered that day. The symptoms resolved after an unspecified time. Additional information has been requested.
pt recv vax 8JAN97 & on 15JAN97 rash noted on face by parent x 1day;seen in office 16JAN97;raised red rash noted on face by 19JAN97;rash inc to trunk & extremities;no fever;pt alert & active;
On 1/3/14, patient developed a choking cough. At 6:30 PM on 1/4/14, he developed a moderate rash all over his body. I took him to the ER. As nothing had changed in his routine or diet to suggest an allergic reaction, the doctors diagnosed it as a possible reaction to his Hepatitis A booster or a viral rash. Prescribed 2.5 mL of Benadryl every 6 hours.
swelling, throbbing, redness around area of inj, soreness in elbow, shoulder & hand of that arm (lt);redness & swelling about 2 inches in diameter;
Initial report received on 13 August 2009 from a physician. A 33 year old female patient, who had no concurrent illnesses, but who has allergy to NEOSPORIN and a history of childhood eczema and scarlet fever, had received a first dose of influenza vaccine in October 2008. The trade name, manufacturer name, lot number, route and site of administration was unknown. Three to four hours post-vaccination, the patient experienced difficulty breathing, swelling of her throat and coughing. The patient contacted her primary care physician and was directed to take BENADRYL. The patient had no further reactions. The recovery status of the patient was not reported. Documents held by sender: None.
RECEIVED HEPATITS A VACCINE #2 IM LEFT DELTOID ON 5/3/2008. ENTIRE LEFT SHOULDER BECAME VERY SORE, WITH PAIN RADIATING TO MID-BACK ON LEFT SIDE. ON 6/1 LEFT AXILLARY AREA  VERY SORE; REPORTED FEELING A LUMP IN THE AXILLA, MOTHER NOT ABLE TO REPORT THE SIZE OF LUMP TO ME. PATIENT IS TAKING TYLENOL FOR THE DISCOMFORT. PAIN IS IMPROVED TODAY; PATIENT WENT TO SCHOOL. MOTHER FELT IT IMPORTANT TO REPORT AS SYMPTOMS SEEM TO INVOLVE THE LYMPHATICS IN AXILLA. WILL SEE MD IF SYMPTOMS DON'T IMPROVE GREATLY BY TOMORROW, 6/3. PATIENTHAS NO SYMPTOMS OF A CONCURRENT ILLNESS AT PRESENT.
Chills, shaking, anxiety and fatigue night after administration. Symptoms resolved by next morning.
Pt to ED 6/3 for cough, headache, shortness of breath, fatigue, and +COVID test at home. Remdesivir and Decadron started, Rocephin and Zithromax continued. 6/5 patient is a&o x4.vital signs are stable, coughing and is complaining of chest pain and headache. 6/6 pt currently on 4L NC satting 91%, pt is A&OX4, denies being in pain with no discomfort or SOB. 6/7 pt alert x 4, denies any pain or discomfort. Pt discharged 6/8.
tired; Fever; headache; he goes to sleep very quickly; nausea; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Feb2021 at 11:00 as a single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On 01Mar2021 at 06:00, the patient experienced nausea and tired, fever, headache, he goes to sleep very quickly on an unspecified date. The outcome of nausea was recovered on an unspecified date in 2021. The outcome of other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
dizziness; This spontaneous case was reported by a non-health professional and describes the occurrence of DIZZINESS (dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Acute L eye edema - inner canthus and medial upper eyelid edema with erythema, pruritus, no blurred vision; improved over 2-3 hrs after benadryl
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 28-DEC-2017, the patient was vaccinated with an improperly storage dose of PROQUAD, lot # N023967, expiration date 28-FEB-2019, (dose number, dose, and route were not reported), for prophylaxis. Other suspect therapies included sterile diluent (MERCK), (Lot number N027626 Expiration date 20-MAY-2019). The PROQUAD and the sterile diluent (MERCK) was on a temperature excursion from 6 to 14 Fahrenheit Degrees during 1 hour and 18 minutes; and from 15 to 46 Fahrenheit Degrees during 34 hours and 29 minutes. Both products had multiple previous temperature excursions. The digital data logger was involved. No adverse effects or reactions had been reported. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1801USA005276.
Fever of 102, tired, achy for 2 days. Sore arm for 4 days (woke up if rolled over on it at night).  Patient said all back to normal after 4 days. Patient took ADVIL.
Pt recv vax on 2/17/99; post vax pt exp red rash x 2 days
After 1st dose tested positive for Covid-19; After 1st dose tested positive for Covid-19; This is a spontaneous report from a Pfizer-sponsored program.  A contactable consumer (patient) reported that a 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient had first vaccine almost 21 days ago, after 1st dose tested positive for covid-19 on an unspecified date. The patient wanted to know if she should have 2nd dose. She stated she has finished her 10-day quarantine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Injection Site pain (beginning at time of injection), Headache (beginning at 5am 4/9/21), fever (100.5-102.0°F, beginning the morning of 4/9/21), muscle pain ( beginning 4/9/21), abdominal pain ( ~8am 4/9/21)
Patient returned to clinic 48 hours after injection with warm, swollen area 3-4 cm in diameter at injection site.
REATION ON L ARM TO SC VZV, MEASURED 50MM X 50MM